Debating on the clinical utility of blood-based biomarkers for Alzheimer diagnosis

Written By Fanny Elahi
Fanny Elahi
Previous

Mount Sinai receives $8 million from DataPhilanthropy to accelerate drug discovery for CADASIL and related brain disorders
Next

Meet the experts who are radically defining what longevity means for women